Wu Yi-Long,Zhou Jianfeng,Zhou Qing,et al.Phase I study of the efficacy and safety of IBI319 in patients with advanced malignant tumors[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA:
Wu, Yi-Long,Zhou, Jianfeng,Zhou, Qing,Zhang, Huilai,Ding, Kefeng...&Ni, Ping.(2022).Phase I study of the efficacy and safety of IBI319 in patients with advanced malignant tumors.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Wu, Yi-Long,et al."Phase I study of the efficacy and safety of IBI319 in patients with advanced malignant tumors".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)